Effect of cryptotanshinone on ferroptosis-related gene expression in lung cancer cells
10.3969/j.issn.1001-1978.2019.12.007
- Author:
Guo-Yao TAN
1
Author Information
1. School of Pharmaceutical Sciences, Sun Yat-sen University
- Publication Type:Journal Article
- Keywords:
A549;
A549/DDP;
Cell survival rate;
Cryptotanshinone;
Ferroptosis;
Gene expression
- From:
Chinese Pharmacological Bulletin
2019;35(12):1654-1658
- CountryChina
- Language:Chinese
-
Abstract:
Aim To investigate the effects of cryptotanshinone on cell viability Aim To investigate the effects of cryptotanshinone on cell viability and ferroptosis-related gene expression in A549 and A549/DDP cells, and to explore its possible mechanisms. Methods A549 and A549/DDP cells were treated with different concentrations of CTS. Cell viability was measured by CCK-8 assay. The mRNA levels of TFR1, DMT1, IREB2, HSPB1, VDAC2, VDAC3 and GPX4 were measured by qPCR, and the protein levels of TFR1 were measured by Western blot. Results The cell viability was down-regulated by CTS in A549 and A549/DDP cells, while the cisplatin-resistant A549/DDP cells were more susceptible to CTS. After CTS treatment, the mRNA levels of ferroptosis-related genes showed different degrees of change. The mRNA levels of HSPB1 and GPX4 increased in A 5 4 9 cells , of which the mRNA levels of IREB2, VDAC2 and VDAC3 were reduced and the mRNA levels of TFR1 and DMT1 exhibited no significant change. The mRNA levels of TFR1 and IREB2 increased in A549/DDP cells, while the mRNA levels of VDAC3 decreased, and the expression levels of DMT1, HSPB1, VDAC2 and GPX4 did not changesignificantly. Conclusions Cryptotanshinone may inhibit the proliferation of lung cancer A549 and A549/DDP cells, and affect the expression of ferroptosis-re-lated genes.
